Valuation: Phaarmasia Limited

Market Cap 580M 6.18M 5.61M 5.19M 4.69M 8.84M 9.15M 62.39M 24.72M 311M 23.19M 22.7M 986M P/E 2025
-12.6x
P/E 2026 2.92x
Enterprise Value 483M 5.15M 4.68M 4.32M 3.9M 7.37M 7.62M 51.96M 20.59M 259M 19.31M 18.91M 822M EV / Sales 2025
0.81x
EV / Sales 2026 0.88x
Free-Float
-
Yield 2025 *
-
Yield 2026 -
1 day+2.35%
1 week+1.16%
Current month+8.61%
1 month-1.10%
3 months+13.53%
6 months+2.49%
Current year-22.83%
1 week 72
Extreme 72
94
1 month 72
Extreme 72
96.75
Current year 67
Extreme 67
131.75
1 year 40.49
Extreme 40.49
131.75
3 years 23.6
Extreme 23.6
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 12/02/2016
Compliance Officer - 03/01/2020
Director TitleAgeSince
Director/Board Member 55 09/12/2012
Chairman 71 14/10/2010
Director/Board Member 63 19/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+2.35%+1.16%+136.35%+222.10% 6.18M
-0.82%+1.40%+39.64%+143.17% 1,275B
-1.12%+0.16%+44.21%+88.24% 680B
-0.16%+0.43%+26.76%+113.01% 521B
-0.83%+1.05%+41.36%+70.88% 389B
-2.23%-2.89%+55.47%+41.64% 356B
-1.66%-0.83%+26.07%+58.57% 305B
-1.87%-0.76%+1.37%+34.29% 287B
-0.72%-0.63%+37.29%+71.87% 250B
-0.30%-1.03%+34.04%+124.88% 208B
Average -0.69%+1.14%+44.26%+96.86% 427B
Weighted average by Cap. -0.94%+0.76%+36.32%+97.27%

Financials

2025 2026
Net sales 244M 2.6M 2.36M 2.18M 1.97M 3.71M 3.84M 26.2M 10.38M 131M 9.74M 9.53M 414M 472M 5.03M 4.57M 4.22M 3.81M 7.19M 7.45M 50.75M 20.11M 253M 18.87M 18.47M 802M
Net income -15.89M -169K -154K -142K -128K -242K -251K -1.71M -677K -8.53M -635K -622K -27.02M 176M 1.87M 1.7M 1.57M 1.42M 2.68M 2.77M 18.89M 7.49M 94.3M 7.02M 6.87M 299M
Net Debt -1.94M -20.63K -18.74K -17.32K -15.64K -29.52K -30.56K -208K -82.51K -1.04M -77.41K -75.77K -3.29M -96.98M -1.03M -938K -867K -783K -1.48M -1.53M -10.43M -4.13M -52.04M -3.88M -3.79M -165M
Projected Income Statement - Annual - Phaarmasia Limited
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
47
Date Price Change Volume
17/11/26 INR 87.00 +2.35% 339
16/11/26 INR 85.00 +7.26% 684
13/11/26 INR 79.25 -7.85% 260
12/11/26 INR 86.00 0.00% 354
11/11/26 INR 86.00 +8.11% 703
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock